1. bookVolume 26 (2019): Issue 4 (December 2019)
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English
access type Open Access

Relationships Between Serum Expression of IGF-1 and Metabolic Syndrome Metrics in Syrian Women with Breast Cancer

Published Online: 17 Feb 2020
Page range: 435 - 443
Received: 12 Aug 2019
Accepted: 20 Dec 2019
Journal Details
License
Format
Journal
First Published
01 May 2012
Publication timeframe
4 times per year
Languages
English

Background and aims: Insulin-like Growth Factors (IGF-1) plays as mediator between metabolic syndrome (MetS), oxidative stress and breast cancer (BrCa) progression. The objective of this study was to examine the relationships between IGF-1 serum levels and metabolic profile biomarkers in a population group of BrCa patients.

Keywords

1. Ferley J, SoerjomataramI I, Ervik M, Dikshit R, Eser S. GLOBOCAN 2012 v1.0. Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer, 2013Search in Google Scholar

2. Luque RM, López-Sánchez LM, Villa-Osaba A et al. Breast cancer is associated to impaired glucose/insulin homeostasis in premenopausal obese/overweight patients. Oncotarget 8(46): 81462-81474, 2017.Search in Google Scholar

3. Wani B, Aziz SA, Ganaie MA, Mir MH. Metabolic Syndrome and Breast Cancer Risk. Indian J Med Paediatr Oncol 38(4): 434–439, 2017.Search in Google Scholar

4. Kim MS, Lee DY. Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus. Ann Pediatr Endocrinol Metab 20(2): 69-73, 2015.Search in Google Scholar

5. Sanford BL, Chandler DS. The Role of the Insulin Receptor Isoforms in the Insulin-Like Growth Factor Signaling Axis in Cancer. Clin Oncology 2: 1236, 2017.Search in Google Scholar

6. Bowers LW, Rossi EL, O’Flanagan CH, deGraffenried LA, Hursting SD. The role of the insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link. Front Endocrinol 6: 77, 2015.Search in Google Scholar

7. Duan L, Maki CG. The IGF-1R/AKT pathway determines cell fate in response to p53. Transl Cancer Res 5: 664-675, 2016.Search in Google Scholar

8. Malaguarnera R, Belfiore A. The emerging role of insulin and insulin-like growth factor signaling in cancer stem cells. Front Endocrinol 5: 10, 2014.Search in Google Scholar

9. Grădinaru D, Khaddour H, Margină D et al. Insulin-Leptin Axis, Cardiometabolic Risk and Oxidative Stress in Elderly with Metabolic Syndrome. Exp Clin Endocrinol Diab 126(7): 445-452, 2018.Search in Google Scholar

10. Grădinaru D, Margină D, Borșa C, et al. Adiponectin: possible link between metabolic stress and oxidative stress in the elderly. Aging Clin Exp Res 29(4): 621-629, 2017.Search in Google Scholar

11. Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer 14: 43, 2015.Search in Google Scholar

12. Liu Y, Zhang J, Huang R, et al. Influence of occupation and education level on breast cancer stage at diagnosis, and treatment options in China: A nationwide, multicenter 10-year epidemiological study. Medicine (Baltimore) 96(15): e6641, 2017.Search in Google Scholar

13. Lewitt MS, Dent MS, Hall K. The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus. J Clin Med 3(4): 1561-1574, 2014.Search in Google Scholar

14. Sun WY, Yun HY, Song YJ, et al. Insulin-like growth factor 1 receptor expression in breast cancer tissue and mammographic density. Mol Clin Oncol 3(3): 572-580, 2015.Search in Google Scholar

15. Li ZJ, Ying XJ, Chen HL, et al. Insulin-like growth factor-1 induces lymphangiogenesis and facilitates lymphatic metastasis in colorectal cancer. World J Gastroenterol 19(43): 7788-7794, 2013.Search in Google Scholar

16. Morgillo F, De Vita F, Antoniol G, et al. Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer. Curr Oncol 20(4): e283–e288, 2013.Search in Google Scholar

17. Kucera R, Treskova I, Vrzalova J, et al. Evaluation of IGF-1 serum levels in malignant melanoma and healthy subjects. Anticancer Res 34(9): 5217-20, 2014.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo